RedHill Biopharma (RDHL) Exchange Rate Effect (2012 - 2022)
RedHill Biopharma (RDHL) posted quarterly Exchange Rate Effect of -$16000.0 for Q4 2022, down 277.78% year-over-year from $9000.0 in Q4 2021, and down 23.08% quarter-over-quarter from -$13000.0 in Q3 2022.
RedHill Biopharma (RDHL) Exchange Rate Effect (2012 - 2022) Analysis & Trends
RedHill Biopharma (RDHL) has reported Exchange Rate Effect for 11 consecutive years, with -$16000.0 the latest figure, recorded in Q4 2022.
- In Q4 2022, Exchange Rate Effect fell 277.78% year-over-year to -$16000.0; the TTM figure through Dec 2022 stood at -$76000.0 (up 21.65% YoY), while the FY2025 annual figure was -$2000.0, down 122.22% from the prior year.
- Exchange Rate Effect retreated to -$16000.0 in Q4 2022 per RDHL's latest filing, from -$13000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $131000.0 in Q1 2020 and bottomed at -$103000.0 in Q1 2021.
- Historically, Exchange Rate Effect has averaged -$2650.0 across 5 years, with a median of -$13500.0 in 2018.
- On a YoY basis, Exchange Rate Effect climbed as much as 718.75% in 2020 and fell as far as 3400.0% in 2020.
- RedHill Biopharma's Exchange Rate Effect stood at -$16000.0 in 2018, then jumped by 437.5% to $54000.0 in 2019, then plunged by 83.33% to $9000.0 in 2020, then changed by 0.0% to $9000.0 in 2021, then plunged by 277.78% to -$16000.0 in 2022.
- Business Quant data shows RDHL's Exchange Rate Effect at -$16000.0 in Q4 2022, -$13000.0 in Q3 2022, and -$32000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -16,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | -32,000.00 |
| Jun 30, 2022 | -32,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Mar 31, 2022 | -15,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Dec 31, 2021 | 9,000.00 |
| Sep 30, 2021 | -17,000.00 |
| Sep 30, 2021 | -17,000.00 |
| Jun 30, 2021 | 14,000.00 |
| Jun 30, 2021 | 14,000.00 |
| Mar 31, 2021 | -103,000.00 |
| Mar 31, 2021 | -103,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Dec 31, 2020 | 9,000.00 |
| Sep 30, 2020 | -33,000.00 |
| Sep 30, 2020 | -33,000.00 |